LON:VAL

ValiRx Interim Earnings Results & Report

ValiRx logo
GBX 0.14 -0.02 (-10.00%)
As of 12:28 PM Eastern

ValiRx reported Interim earnings on September 15, 2026. The company reported EPS of -GBX 0.09.

Earnings Announcement Details

Quarter
Interim
Time
Before Market Opens

ValiRx EPS Results

Actual EPS
-GBX 0.09
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

ValiRx Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

ValiRx Interim Earnings FAQ

ValiRx (LON:VAL) reported earnings of -GBX 0.09 per share for Interim. The report was announced on Tuesday, September 15, 2026.

ValiRx Earnings Headlines

Update on Ambrose Healthcare shareholding
What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
See More ValiRx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ValiRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ValiRx and other key companies, straight to your email.

About ValiRx

ValiRx (LON:VAL) accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

View ValiRx Profile